Home › Employers › Bjrx Pharmacy LTC, Inc.
Bjrx Pharmacy LTC, Inc.: H-1B salaries and sponsorship
Bjrx Pharmacy LTC, Inc. filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $74,027.
Does Bjrx Pharmacy LTC, Inc. sponsor H-1B visas?
Bjrx Pharmacy LTC, Inc. filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Aug 26, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Compounding Chemist | 1 | $60,424 |
| Pharmacist | 1 | $135,200 |
| Database Administrator | 1 | $71,011 |
| Clinical Services Coordinator | 1 | $77,043 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2025 | 4 | $74,027 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Clinical Services Coordinator | $77,043 Level I | Stockton, CA | Aug 26, 2025 | Sep 15, 2025 | Certified |
| Compounding Chemist | $60,424 Level I | Stockton, CA | Jun 10, 2025 | Oct 1, 2025 | Certified |
| Pharmacist | $135,200 Level I | Stockton, CA | May 21, 2025 | Oct 1, 2025 | Certified |
| Database Administrator | $71,011 Level I | Stockton, CA | Apr 17, 2025 | Apr 28, 2025 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).